Institutions / Elmind Capital, LP / Holdings
Back to Elmind Capital, LP

Elmind Capital, LP

All holdings · as of Dec 31, 2025

34 positions

CompanyClassValue ↓Shares% of portfolio
Cogent Biosciences, Inc.—$41.58M1,170,74012.3%
Syndax Pharmaceuticals Inc—$38.97M1,855,00011.5%
Viridian Therapeutics, Inc.—$26.72M858,6317.9%
Vera Therapeutics, Inc.—$24.43M482,5007.2%
Celldex Therapeutics, Inc.—$23.49M865,0006.9%
CG Oncology, Inc.—$20.45M492,5006.0%
BIOCRYST PHARMACEUTICALS INC—$16.77M2,150,0004.9%
VAXCYTE, INC.—$13.45M291,5004.0%
Beam Therapeutics Inc.—$13.20M476,3383.9%
Pharvaris N.V.—$13.20M475,7503.9%
KalVista Pharmaceuticals Inc—$12.94M801,3003.8%
DYNAVAX TECHNOLOGIES CORP—$10.46M679,9003.1%
Tyra Biosciences, Inc.—$9.20M350,0002.7%
Nurix Therapeutics, Inc.—$8.73M460,0002.6%
WAVE LIFE SCIENCES LTD—$7.61M447,8462.2%
MBX Biosciences, Inc.MBXCommon Stock$6.65M211,0002.0%
Krystal Biotech, Inc.—$5.42M22,0001.6%
United Therapeutics Corp—$5.36M11,0001.6%
BioMarin Pharmaceutical Inc—$4.87M82,0001.4%
Relay Therapeutics, Inc.—$4.54M536,9461.3%
Travere Therapeutics, Inc.—$4.20M110,0001.2%
PROTAGONIST THERAPEUTICS INC—$3.32M38,0001.0%
Cullinan Therapeutics, Inc.—$3.21M310,0000.9%
Liquidia CorpLQDACommon Stock$3.10M90,0000.9%
CytomX Therapeutics, Inc.—$2.98M700,0000.9%
UROGEN PHARMA LTD—$2.34M100,0000.7%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$2.02M58,2480.6%
Design Therapeutics, Inc.DSGNCommon Stock$1.95M207,9000.6%
enGene Therapeutics Inc.—$1.90M210,0000.6%
Alector, Inc.—$1.40M900,0000.4%
Amylyx Pharmaceuticals, Inc.—$1.35M112,0000.4%
Apellis Pharmaceuticals, Inc.—$1.26M50,0000.4%
Supernus Pharmaceuticals Inc—$994.0K20,0000.3%
Edgewise Therapeutics, Inc.—$744.5K30,0000.2%
← PrevPage 1 of 1Next →